Peptide Vault vs Paramount Peptides: A Documentation Comparison

The thing that makes vendor comparison so tiring in this market is how little the loud parts of a site vary. Two companies can publish identical purity percentages, identical “third-party tested” badges and identical USA framing while running completely different operations underneath, and none of that surface copy helps you predict what shows up in the vial.

So the only useful comparison is of what each company will put in writing: who ran the synthesis, which laboratory signed the report, which assays were on the panel, whether a certificate is tied to a lot number you can find on the label, and what’s actually in a blend. I read both sites the same day with those questions in hand, and I’ve quoted the pages rather than summarising them.

One disclosure before the rows. I write for a peptide manufacturer, neither Peptide Vault nor Paramount Peptides is that manufacturer, and nothing here routes you toward anything of mine. Everything below was publicly readable on the pages I reviewed on 2026-09-08, and gaps are described as gaps in what was published, not as conclusions about either company.

Key takeaways

• Documentation is the only part of a supplier you can inspect before your money moves, which is why a named laboratory, a stated method and a lot number outrank a purity banner.
• Peptide Vault publicly states testing “for identity, purity, and quantity by HPLC and mass spectrometry” and publishes a searchable batch index carrying purity figures and an endotoxin column.
• Paramount Peptides publicly states that its peptides are “crafted in-house, from the initial design and synthesis to the final purification and quality testing,” and names the analyzing laboratory on product pages.
• Neither company published a bacterial endotoxin and sterility pair on the pages reviewed 2026-09-08, and neither published a sterility result at all.
• Everything discussed here is research material intended for in-vitro laboratory work by qualified professionals.

Which five checks decide a vendor comparison?

Here’s the rubric, set before either name appears so it can’t be tuned to flatter the site that reads better.

Provenance comes first. Does the company state that it synthesizes the peptide, or does it describe supplying, producing, stocking, or making it available? Both describe real businesses, and a careful supplier can beat a careless manufacturer on any given lot. But the two hold different records, and when material behaves oddly six months on, only the company that ran the synthesis can pull the file and tell you what happened.

Second, is the laboratory named? I weigh this above the purity number itself. A named laboratory is something you can look up independently, phone, and ask whether a report number is genuinely theirs.

Third, how wide is the panel? Four assays answer four different questions. HPLC purity measures what fraction of the material is a single compound. Mass spectrometry confirms which compound it is. Bacterial endotoxin and sterility describe the finished vial rather than the powder, and that pair is what matters for anything cell-based. Publishing one of the four is ordinary here.

Fourth, can you read a batch certificate before paying, and does that document’s lot number appear on the vial you receive? Both conditions together are what make a certificate evidence about your material rather than a representative sample of the company’s testing programme. A library with no lot linkage documents a process. A lot-linked certificate documents your purchase.

Fifth, on blends, are the milligrams stated per component? The same blend name at two vendors can hide two different ratios, and without the split you can’t calculate a working concentration. Company age and domain age stay off this list entirely, because neither one describes a lot.

The standard used in this comparison

I’d rather name where the yardstick came from than pretend it arrived from nowhere. These five checks are the ones Blank Peptides publishes its own lots against: in-house cGMP synthesis, named testing laboratories, a per-lot panel covering identity, purity, bacterial endotoxin and sterility, batch certificates of analysis keyed to the lot number printed on every vial, and blend composition disclosed per component. Neither company below is that one, which is worth knowing before you read the rows.

What Peptide Vault publicly states

A clarification first, because search results muddle this one. Peptidevault.com resolved to a domain-for-sale page on 2026-09-08, and the site reviewed here is peptidevaultlabs.com, trading as Peptide Vault Labs.

On provenance, the homepage states products are “Made in the USA” and “Produced in a controlled U.S. facility under strict laboratory standards,” while the about page states the company “supplies research-grade peptides and laboratory materials to researchers, institutions, and analytical labs.” The verb that recurs across those pages is “supplies.” Whether the company owns the facility described, or performs the synthesis inside it, was not listed on the pages reviewed 2026-09-08. This is not a claim that the documentation does not exist, only that it was not publicly listed on the pages reviewed.

On testing, the site states “Third-Party Batch Tested” and refers to “independent analytical documentation.” The COA library header states that “Every batch is third-party tested for identity, purity, and quantity by HPLC and mass spectrometry,” and a “≥99% Purity Standard” appears across the site. Naming both assays by method is more specificity than a good deal of this market offers. No laboratory was named on any page I reviewed on 2026-09-08.

The batch index is the strongest thing on the site, and it earns a concession I’ll give plainly. It states: “Search published analytical records by product or batch number,” and rows carry batch identifiers in a PVL-prefixed format, purity figures running from roughly 99.08% to 99.62%, and an endotoxin column reading “None.” That endotoxin column is worth flagging, because it’s a row the other company in this comparison doesn’t publish at all, and endotoxin is one of the two results this market skips most often. Sterility was not among the listed parameters, and I couldn’t find a downloadable certificate document behind any individual row, which is the gap between a published result and a laboratory’s signed report.

On blends, the site lists four: KLOW at 80 mg, GLOW, CJC-1295 with Ipamorelin at 10 mg, and BPC-157 with TB-500 at 10 mg. The KLOW page states it is “formulated with BPC-157, TB-500, GHK-Cu, and KPV,” and the GLOW page names BPC-157, TB-500 and GHK-Cu. Milligrams per component were not listed, and the GLOW total appeared as 80 mg on the shop grid against 70 mg on its own product page. The site advertises “Same-Day Fulfillment,” and the footer states products are “not intended for human or veterinary use.”

What Paramount Peptides publicly states

Paramount Peptides operates at paramountpeptides.com, and on the provenance question it makes the most direct claim of any site in this comparison.

The about page states the company is “an American-owned and operated research peptide manufacturer based in Southern California,” gives an Irvine, California address, and states that “our peptides are proudly crafted in-house, from the initial design and synthesis to the final purification and quality testing.” It adds that “unlike many other companies in the industry, we do not purchase finished products or rely on third-party manufacturers,” describes that arrangement as vertical integration, and states “we are not a compounding facility. Instead, we specialize in the precise synthesis of peptides.” Raw inputs get addressed separately, with the page stating that “every component that goes into our peptides is sourced from trusted and accredited suppliers,” which reads as buying starting materials rather than finished vials.

On testing, the homepage states that products undergo HPLC and mass spectrometry analysis, that a Certificate of Analysis stands behind every batch, and that purity exceeds 99%. Product pages carry a purity line reading “≥99% by HPLC | COA available” alongside a Quality Documents section, and that section names the analyzing laboratory, gives a batch and lot code, an analysis date, and a link to the document itself. The BPC-157 10mg page reviewed listed a lot code with an analysis date of June 20, 2025. A separate certificates page states “search by lot number or product name” and that “the lot number is printed on the product label,” which closes the loop between document and vial in a way most sites don’t attempt. Bacterial endotoxin and sterility were not listed on the pages reviewed 2026-09-08.

Blend disclosure is where Paramount Peptides is most complete. The blends category listed 16 products with the split written into the name, including “GLOW 70 – GHK-CU (50mg) / BPC-157 (10mg) / TB500 (10mg)” and “4X Blend GHRP-2 (5mg) / Tesamorelin (5mg) / MGF (500mcg) / Ipamorelin (2.5mg).”

The concession here is straightforward to make. Stating in-house synthesis, naming the analyzing laboratory on the product page, tying certificates to searchable lot numbers that also appear on the label, and writing per-component milligrams into blend titles puts Paramount Peptides ahead on four rows at once, and the lot-on-the-label detail is the single hardest thing in this rubric to fake. The homepage also states free shipping over $300 and a guarantee refunding a $100 independent test fee plus the order value if a buyer’s own HPLC result comes back negative.

Side by side: provenance claims and lot-tied certificates

How to verify either supplier yourself

• Take the laboratory name off a Paramount Peptides product page, look that laboratory up through your own search rather than a supplied link, and phone them to ask whether the lot code and report belong to them. This is the check that separates a real certificate from a designed one.
• Ask Peptide Vault for the signed laboratory report behind a batch index row rather than the row itself. A published figure and a laboratory’s own document are different objects, and only the second names an issuer you can contact.
• Order-of-operations matters on the lot question. Ask each company for the certificate covering the lot they would ship you this week, then compare that identifier against what arrives on the label.
• Ask both about sterility, since neither published a sterility result on the pages reviewed 2026-09-08, and ask Paramount Peptides about endotoxin specifically, since that row wasn’t listed on the pages reviewed either.
• Score both against the supplier verification checklist so the same rows get filled in for each company rather than the rows each site makes easy.

Further reading

• Who Actually Manufactures Research Peptides in the USA?
• Which Peptide Vendors Name Their Testing Lab?
• Peptide Vendors With Public Per-Batch COA Libraries
• Which Peptide Vendors Disclose Blend Composition?

Frequently asked questions

Peptide Vault vs Paramount Peptides: which one documents more?

Paramount Peptides documents more on four of the five rubric rows, stating in-house synthesis, naming the analyzing laboratory on product pages, tying certificates to lot numbers printed on the label, and writing per-component milligrams into blend titles. Peptide Vault publishes an endotoxin column that Paramount Peptides doesn’t list at all on the pages reviewed 2026-09-08.

Does either company name its testing laboratory?

Paramount Peptides does, in the Quality Documents section of its product pages, alongside a batch and lot code and an analysis date. Peptide Vault refers to “independent laboratory testing” without naming anyone on the pages reviewed 2026-09-08. Either way, look the named laboratory up independently and confirm the report number with it directly rather than trusting the page it appeared on.

Why does a lot number printed on the label matter so much?

Because it’s the only thing connecting a document to your specific vial. A certificate library with no lot linkage tells you a company runs tests. A certificate you can look up by a number printed on the vial in your hand tells you what was in that vial.

Do either of them publish a sterility result?

Neither did on the pages reviewed 2026-09-08. Peptide Vault’s batch index carries an endotoxin column reading “None,” which covers one of that pair. Paramount Peptides listed neither endotoxin nor sterility. Both are the rows this market skips most often, so ask about them in writing before assuming a panel covers them.

Are these products for human use?

No. Everything referenced here is research material intended for in-vitro laboratory work by qualified professionals. Purity figures, laboratory names, batch indexes and certificate libraries describe documentation and nothing more. Nothing in this article is dosing guidance, medical advice, or a recommendation to use any compound outside a controlled laboratory setting.

For research use only. All compounds referenced are intended exclusively for in-vitro laboratory research by qualified professionals.

Written by Blank Peptides Research Team

Peptide science researchers with 5+ years in US-based peptide manufacturing, independent HPLC and mass spectrometry testing, and research education. All content is reviewed for scientific accuracy before publication.

REVIEWED BY

Dr. Tobias S — PhD Chemist, Peptide and Unnatural Amino Acid Synthesis

Dr. Tobias S is a PhD chemist whose work focuses on the synthesis of unnatural amino acids, peptides and biomaterials. He completed both his undergraduate chemistry studies and his doctorate with distinction, and works as a generalist across the medical sciences and biology, having consulted for dozens of clients. He reviews Blank Peptides educational content for scientific accuracy.

Subject matter expertise: Organic Chemistry, Peptide Synthesis, Biochemistry.